Digital PCR Market Business Opportunities Forecast To 2028

According to Precision Business Insights (PBI), the latest report, the digital PCR market is expected to be worth USD 5.2 billion in 2022, growing at a 9.1% CAGR from 2022 to 2028. The global digital PCR market is segmented into the following types: By Technology (Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR), By Product Type (Digital PCR Systems, Consumables and Reagents, Software and Services), By Application (Clinical Diagnostics, Research, Forensic and Others,), By End User (Pharmaceuticals and Biotechnology Industries, Clinical Diagnostic Laboratories, Universities and Other Organizations) and Geography (North America, Europe, Asia Pacific, Latin America, and MEA) Forecast to 2028. Key players' profiles in the digital PCR market report are Avance Biosciences, Bio-Rad Laboratories, Inc., Fluidigm Corporation, jn medsys, Merck KGaA, Precigenome LLC, QIAGEN N.V, STILLA TECHNOLOGIES, sysmex corporation, and Thermo Fisher Scientific, Inc. The primary reasons propelling the growth of the dPCR Market during the forecast period are the increasing prevalence of genetic disorders, target infectious diseases, growing usage of biomarker profiling for disease diagnostics, and the actual execution of the Human Genome Project. In the upcoming years, it is anticipated that the demand for dPCR will rise due to increased technological breakthroughs in PCR technologies and growing investments, funding, and grants. Increases in the prevalence of target diseases around the world coupled with the dPCR Market Analysis's (verified) effectiveness in identifying and valuing disease-causing microbes will encourage the use of clinical diagnostic tests, including dPCR Market Analysis, which is anticipated to boost market growth over the course of the forecast period.

View Detailed Report Description Here - https://precisionbusinessinsights.com/market-reports/digital-pcr-market/

Droplet digital PCR Segment to Dominate the Digital PCR Market:
The droplet digital PCR segment is expected to account for a larger revenue share in the global digital PCR market, with a value share worldwide. It is projected to grow at a 9.3% CAGR between 2022 and 2028. Droplet digital PCR (ddPCR), a technique for carrying out digital PCR, is based on the droplet technology of a water-oil emulsion. A sample is divided into 20,000 droplets, and PCR amplifies the template molecules in each droplet. The reagents and procedures utilized by the ddPCR method are comparable to those of the most common TaqMan probe-based tests. A crucial component of the ddPCR process is the large sample splitting. In addition to the benefits of the ddPCR, the rising incidence of infectious diseases, cancer, and increased financing for biotechnology are all driving the segment's expansion.

Europe Digital PCR Market:
The Europe market is expected to increase in the global digital PCR market over the forecast period. It is projected to grow at a CAGR of 9.3% in the coming years. In Europe, one of the key nations in pharmaceutical research and development in Germany. By integrating genetic analysis technologies, pioneering approaches like targeted therapy and personalized precision medicine are being developed and made manifest. Germany provides significant institutional financing for research and development, which has improved the caliber of research across Europe. The region has seen a rise in the use of molecular diagnostics due to the prevalence of diseases, and the application of microarray, PCR, and other genomic and proteomic research technologies is driving the field of precision diagnosis.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=46037

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global digital PCR market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In 2020, Danaher Corporation received the US FDA Emergency Use Authorization (EUA) for the Xpert Xpress SARS-CoV-2 test. In 2020, Thermo Fisher Scientific, Inc., received US FDA emergency use authorization (EUA) for SARS-CoV-2 multiplex real-time PCR test. In 2020, Roche Diagnostics acquired FDA 510k clearance for the Cobas BKV test.

Detailed Segmentation:
Based on the technology, the market is segmented into the following:
• Droplet Digital PCR
• Chip Based Digital PCR
• Beaming Digital PCR

Based on the product type, the market is segmented into the following:
• Digital PCR Systems
• Consumables and Reagents
• Software and Services

Based on the application, the market is segmented into the following:
• Clinical Diagnostics
• Forensic and Others
• Research

Based on the end user, the market is segmented into the following:
• Pharmaceuticals and Biotechnology Industries
• Clinical Diagnostic Laboratories
• Universities and Other Organizations

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=46037

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.